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Abstract
Primary lymphoma of the adrenal gland is a rare and highly aggressive disease, with only a few
reports in the literature. The pathogenesis is unknown, but detection of Epstein Barr virus (EBV)
genome sequences and gene expression in some cases of primary adrenal lymphomas suggested
the virus might be a causative agent of the malignancy. While investigating the presence of genome
sequences of oncogenic viruses in a large series of adrenal tumors, both EBV and JC polyomavirus
(JCV) DNA sequences were detected in a diffuse large primary bilateral B-cell non-Hodgkin
lymphoma of the adrenal gland, which was diagnosed only at postmortem examination in a 77 year-
old woman with incidentally discovered adrenal masses and primary adrenal insufficiency. The
presence of both EBV and JCV genome sequences suggests the relevance of EBV and JCV
coinfection in the pathogenesis of this rare form of B-cell lymphoma.
Findings
Primary lymphoma of the adrenal gland is a rare and
highly aggressive disease, with only a few reports in the lit-
erature [1-3]. It generally affects elderly individuals, espe-
cially those with a history of cancer, HIV infection, or
autoimmune disorders, and, in about 50% of cases, it
presents with symptoms of adrenal insufficiency due to
bilateral adrenal involvement. Histologically, the most
common type of primary adrenal lymphomas is diffuse
large B-cell lymphoma [3]. Treatment with chemotherapy
according to the CHOP-regimen (cyclophosphamide,
doxorubicin, vincristine, prednisone) alone or in combi-
nation with rituximab has led complete or partial remis-
sion is some patients, even though prognosis remains
poor with death occurring within one year after diagnosis
[3-5]. The pathogenesis is unknown, but detection of
Epstein Barr virus (EBV) genome sequences and gene
expression in 9 out of 20 cases of primary adrenal lym-
phomas suggested the virus might be the causative agent
of the malignancy [6]. While investigating the presence of
genome sequences of oncogenic viruses in a large series of
adrenal tumors and their potential association with
malignancy [7], both EBV and JC polyomavirus (JCV)
DNA sequences were detected in the case of primary bilat-
eral adrenal B-cell lymphoma we are reporting here.
The patient was a 77-yr woman with bilateral adrenal
masses which were incidentally discovered at abdominal
ultrasonography performed for dispepsia and weigth loss.
The past history of the patients was unremarkable except
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firmed the presence of bilateral (right adrenal mass maxi-
mum diameter, 5 cm; left adrenal mass maximum
diameter, 7 cm) solid and heterogeneous adrenal masses
which probably infiltrated the liver. Brain and bone CT-
scans were negative. Laboratory evaluation demonstrated
the presence of anemia, increased erythrosedimentation
rate, and the presence of monoclonal G immunoglobu-
lins, while autoantibodies testing was negative. Endocrine
evaluation demonstrated primary adrenal insufficiency,
since all adrenal steroids were low and adrenocorticotro-
pin levels were markedly elevated. Replacement therapy
with cortisone was started, resulting in immediate
improvement of symptoms. Repeated chest-abdominal
CT-scan performed after 3 months showed increased mass
size with areas of colliquation and the presence of left
pleural effusion. Bilateral nonvisualization at adrenal
scintiscan suggested the presence of malignant or space-
occupying adrenal lesions [8]. Fine needle aspiration
biopsy was not performed because bilateral adrenocorti-
cal carcinoma or metastases were suspected based on CT-
scan and scintigraphic appearance. At 5 months from
diagnosis, the patient died because of advanced disease.
Postmortem examination revealed bilateral involvement
of adrenal glands by encapsulated masses with a solid, fri-
able, grayish-white cut surface and extensive necrosis.
Microscopic features consisted of large transformed lym-
phoid cells with pleomorphic vesicular nuclei with prom-
inent nucleoli (Fig. 1a). Upon immunohistochemical
analysis, the neoplastic cells expressed the B cell marker
CD20 (Fig. 1b). A diagnosis of diffuse large B-cell non-
Hodgkin lymphoma was made. To investigate whether
oncogenic viruses were involved in the disease, both left
and right adrenal masses were examined for the presence
of all human herpesviruses and polyomaviruses by quan-
titative real-time PCR, as reported [7]. EBV DNA was
present at high titre (about 100 genome copies/cell) and
JCV DNA at lower titre (about 0.1 genome copy/cell) in
both adrenal masses. EBV genotyping by PCR amplifica-
tion of the EBNA-2 and EBNA-3B genes [9] demonstrated
EBV type 1, while sequencing of the JCV VP1 gene [10]
classified JCV as type 1B (Fig. 2), which are the genotypes
most commonly found in our country. Moreover, PCR-
amplification of both large T antigen (TAg) and the VP1
sequences suggested that the entire JCV genome was
present. EBV and JCV DNA was not detected in other tis-
sues (lymph nodes, spleen, liver, kidney). Both immuno-
histochemical staining and western blot analysis of JCV
TAg expression in lymphoma samples, which were per-
formed with an anti-SV40 TAg cross-reacting antibody
(Calbiochem, Anti-SV40 T Antigen Ab-2, Pab416) as
reported [7], gave negative results. It cannot however be
excluded that lack of JCV TAg detection was due to the rel-
atively low number of JCV-positive cells and to the poor
quality of tissue samples.
While EBV is a recognized causative agent of B-cell lym-
phomas, the association between JCV and hematologic
malignancies is matter of debate. A potential implication
of JCV in B-cell lymphomas is suggested by its oncogenic-
ity in vitro and in animal models [11] and by its ability to
infect B-lymphocytes [12], where it seems to cause chro-
mosomal damage [13]. Indeed, JCV DNA and gene
expression have been detected in 4 of 63 (6%) non-Hodg-
kin lymphomas and in 1 of 20 (5%) Hodgkin lymphomas
[14], in a primary B-cell lymphoma of the central nervous
system occurring in a patient with AIDS and concurrent
progressive multifocal leucoencephalopathy [15], and in
22 of 27 (81%) primary B-cell lymphomas of the central
nervous system, including 14 which also contained EBV
DNA [16]. However, it remains unknown whether JCV
has a causal role in human neoplasia. Our report of a pri-
a) Non-Hodgkin lymphoma and glandular structures (H & E; original magnif cation 400×); b) immunostaining showing neo-plastic cells positive for CD20 (original m gnificati n 400×)Figure 1
a) Non-Hodgkin lymphoma and glandular structures 
(H & E; original magnification 400×); b) immunos-
taining showing neoplastic cells positive for CD20 
(original magnification 400×).Page 2 of 4
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EBV DNA, even if it does not provide evidence for a causal
relationship between viral infection and development of
lymphoma, could support the hypothesis by Del Valle et
al. [16] that JCV might act as a co-factor of EBV in B-cell
transformation. However, since we did not evaluate
whether the patient had systemic JCV infection before
death, we cannot exclude a secondary involvement of
lymphoma cells in the course of a systemic infection due
to JCV reactivation in a terminally-ill patient. This is also
suggested by the relatively low JCV DNA load (0.1 copies/
cell) in tumor tissues.
In conclusion, we demonstrated the presence of both EBV
and JCV genome sequences in a diffuse large B-cell non-
Hodgkin lymphoma of the adrenal gland. Further studies
in other cases are encouraged to clarify the relevance of
EBV and JCV coinfection in the pathogenesis of this rare
form of extranodal B-cell lymphoma.
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Electropherogram of the JCV VP1 gene fragment sequence amplified from the primary adrenal lymphomaFigu e 2
Electropherogram of the JCV VP1 gene fragment sequence amplified from the primary adrenal lymphoma. 
PCR amplification and sequencing was performed by using the JLP-15 and JLP-16 primers reported by Agostini et al. [10]. 
Nucleotides that are critical for genotyping are underlined.Page 3 of 4
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